menu
    • menu

    Company profile for Bellicum Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bellicum is a clinical-stage biopharmaceutical company that is driving the future of cellular IO. We discover and develop product candidates in some of the most important areas of cellular immunotherapy, with a focus on CAR-T and allogeneic cell therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bellicum PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Life Science Plaza 2130 West Holcombe Boulevard, Suite 800 Houston, Texas 7703...
    Telephone
    Telephone
    (832) 384-1100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bellicum.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bellicum
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/BellicumPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bellicum halts trials after serious adverse event, looks for 'alternatives'
    Bellicum halts trials after serious adverse event, looks for 'alternatives'

    16 Mar 2023

    // Katherine Lewin ENDPTS

    https://endpts.com/bellicum-halts-trials-after-serious-adverse-event-looks-for-strategic-alternatives/

    Katherine Lewin ENDPTS
    16 Mar 2023
    Share Share
    Bellicum Presents Early PI Results for BPX-601 in Prostate Cancer at ASCO GU
    Bellicum Presents Early PI Results for BPX-601 in Prostate Cancer at ASCO GU

    16 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/16/2609615/0/en/Bellicum-Presents-Early-Phase-1-Results-for-BPX-601-in-Prostate-Cancer-at-ASCO-GU-Cancers-Symposium.html

    GLOBENEWSWIRE
    16 Feb 2023
    Share Share
    Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    31 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/31/2599032/0/en/CORRECTION-Bellicum-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    31 Jan 2023
    Share Share
    Bellicum to Present Phase 1 Results for BPX-601 in Prostate Cancer at ASCO
    Bellicum to Present Phase 1 Results for BPX-601 in Prostate Cancer at ASCO

    19 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/19/2591682/0/en/Bellicum-Pharmaceuticals-to-Present-Early-Phase-1-Results-for-BPX-601-in-Prostate-Cancer-at-ASCO-2023-Genitourinary-Cancers-Symposium.html

    GLOBENEWSWIRE
    19 Jan 2023
    Share Share
    Bellicum Announces Presentatioat on Abrogation of iC9 CAR T-Cell Toxicities
    Bellicum Announces Presentatioat on Abrogation of iC9 CAR T-Cell Toxicities

    11 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/12/11/2571433/0/en/Bellicum-Announces-Presentation-by-UNC-at-ASH-2022-on-Potential-Abrogation-of-iC9-CAR-T-Cell-Toxicities-with-Rimiducid.html

    GLOBENEWSWIRE
    11 Dec 2022
    Share Share
    Bellicum Pharmaceuticals to Participate in the 2022 Cell & Gene Meeting
    Bellicum Pharmaceuticals to Participate in the 2022 Cell & Gene Meeting

    04 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/04/2527684/0/en/Bellicum-Pharmaceuticals-to-Participate-in-the-2022-Cell-Gene-Meeting-on-the-Mesa.html

    GLOBENEWSWIRE
    04 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Contact Bellicum Pharmaceuticals and get a quotation

    Bellicum Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Rimiducid bulk with DMF offered by Bellicum Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search